短信干预支持2型糖尿病自我管理:DiabeText临床试验
DiabeText是一项在西班牙巴利阿里群岛开展的实用型12个月双臂随机临床试验,纳入742例血糖控制不佳(HbA1c>7.5)的2型糖尿病初级保健患者。干预组在常规照护外接受167条针对健康生活方式和用药依从性的定制短信。结果显示两组HbA1c无显著差异,但干预组在自我报告的用药依从性、糖尿病自我效能感和健康相关生活质量方面有显著改善。
要点
- DiabeText短信干预未显著改善HbA1c水平(β=-0.025,95%CI=-0.198至0.147,P=0.772)。
- 干预组自我报告用药依从性显著改善(OR=1.4,95%CI=1.0至1.9)。
- 干预组糖尿病自我效能感(Cohen's d=0.35)和EQ-5D-5L生活质量(Cohen's d=0.18)显著改善。
核心结论
- DiabeText短信干预成功改善了初级保健2型糖尿病患者的健康相关生活质量、糖尿病自我管理和自我报告用药依从性。
- 干预对血糖控制(HbA1c)无显著影响,需进一步研究增强其对生理结局的效果。
研究设计与样本
- 实用型三期、12个月、双臂随机临床试验,在西班牙巴利阿里群岛城市和农村初级保健机构开展。
- 共纳入742例血糖控制不佳(HbA1c>7.5)的2型糖尿病患者,随机分配至常规照护对照组或DiabeText干预组。
- 干预组在常规照护外接受167条针对健康生活方式和用药依从性的定制短信。
主要发现
- 12个月时两组HbA1c无统计学显著差异(β=-0.025,95%CI=-0.198至0.147,P=0.772)。
- 干预组自我报告用药依从性显著改善(OR=1.4,95%CI=1.0至1.9,P<0.05)。
- 干预组糖尿病自我效能感(DSES,Cohen's d=0.35)和健康相关生活质量(EQ-5D-5L,Cohen's d=0.18)显著改善(P<0.05)。
- 其他次要结局(药物持有率、地中海饮食依从性、体力活动)未见显著改善。
关键数值与推荐
- 纳入标准:2型糖尿病且HbA1c>7.5。
- 干预内容:167条定制短信,聚焦健康生活方式和用药依从性。
- 主要结局:HbA1c水平;次要结局包括用药依从性、EQ-5D-5L、DSES、MEDAS-14、IPAQ。
临床怎么用
- 在初级保健中,可考虑将理论驱动的定制短信干预作为辅助工具,改善2型糖尿病患者的自我管理行为、用药依从性和生活质量。
- 短信干预对血糖控制的直接效果有限,不应替代常规降糖治疗,需结合其他策略优化生理结局。
局限性
- 研究未报告样本量计算依据、盲法实施细节及失访情况。
- 次要结局多为自我报告,可能存在报告偏倚。
- 干预周期12个月,长期效果未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complications arising from uncontrolled type 2 diabetes mellitus (T2DM) pose a significant burden on individuals' wellbeing and healthcare resources. Digital interventions may play a key role in mitigating such complications by supporting patients to adequately self-manage their condition. AIM: To assess the impact of DiabeText, a new theory-based, patient-centred, mobile health intervention integrated with electronic health records to send tailored short text messages to support T2DM self-management. DESIGN AND SETTING: A pragmatic, phase-three, 12-month, two-arm randomised clinical trial involving primary care patients with T2DM in the Balearic Islands, Spain, including in urban and rural areas. METHOD: In total, 742 participants with suboptimal glycaemic control (glycated haemoglobin [HbA1c] level >7.5) were randomly allocated to a control (usual care) or intervention (DiabeText) group. In addition to usual care, the DiabeText group received 167 messages focused on healthy lifestyle and medication adherence. The primary outcome was HbA1c level. Secondary outcomes were: medication possession ratio; health-related quality of life (measured using the EQ-5D-5L questionnaire); diabetes self-efficacy (measured using the Diabetes Self-Efficacy Scale [DSES]); and self-reported adherence to medication, Mediterranean diet (measured using the 14-Item Mediterranean Diet Adherence Screener [MEDAS-14]), and physical activity (measured using the International Physical Activity Questionnaire [IPAQ]). RESULTS: Over the 12-month period, no statistically significant differences in HbA1c were observed between the intervention and the control groups (β = -0.025 [95% confidence interval {CI} = -0.198 to 0.147; P = 0.772]). In comparison with the control group, the DiabeText group showed significant (P<0.05) improvements in self-reported medication adherence (odds ratio = 1.4; 95% CI = 1.0 to 1.9), DSES (Cohen's d = 0.35), and EQ-5D-5L (Cohen's d = 0.18) scores, but not for the rest of the secondary outcomes. CONCLUSION: DiabeText successfully improved quality of life, diabetes self-management, and self-reported medication adherence in primary care patients with T2DM. Further research is needed to enhance its effects on physiological outcomes.
引用
- Zamanillo-Campos R, Fiol-deRoque MA, Serrano-Ripoll MJ, et al. Impact of an SMS intervention to support type 2 diabetes self-management: DiabeText clinical trial. Br J Gen Pract. 2025. PMID: 39362693. doi:10.3399/BJGP.2024.0206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。